全胰腺切除术后复发性低血糖风险与长期生存的前瞻性观察研究
该单中心前瞻性观察研究分析2009至2024年147例全胰腺切除患者,其中76例单纯全胰腺切除、71例联合胰岛自体移植。单纯全胰腺切除患者低血糖相关死亡2例(2.63%),血糖控制与胰岛素依赖的移植组相似。研究提示现代胰岛素与持续葡萄糖监测使全胰腺切除后严重低血糖风险低于既往报告。
要点
- 全胰腺切除后严重低血糖风险低于历史报告的41%,现代管理下结局可接受。
- 单纯全胰腺切除与胰岛自体移植胰岛素依赖组在血糖控制与住院就诊方面相似。
- 14天持续葡萄糖监测未观察到单纯全胰腺切除患者出现严重低血糖(<3.0 mmol/L)。
核心结论
- 现代胰岛素疗法与持续葡萄糖监测使全胰腺切除后严重低血糖风险低于既往报告,结局可接受。
- 该数据有助于外科决策与患者选择。
研究设计与样本
- 单中心前瞻性观察研究,分析2009至2024年147例全胰腺切除患者,其中76例单纯全胰腺切除、71例联合胰岛自体移植。
- 研究提供Dexcom G7持续葡萄糖监测(CGM)给无CGM的患者,评估人口学、生存、急诊就诊与血糖控制。
主要发现
- 单纯全胰腺切除患者中2例死亡与低血糖相关(2/76;2.63%)。
- 术前单纯全胰腺切除患者HbA1c(7.1±2.2%)高于胰岛自体移植患者(5.9±1.3%;P<0.001)。
- 术后第一个月单纯全胰腺切除患者HbA1c高于胰岛自体移植胰岛素依赖患者,但10年内无差异。
- 单纯全胰腺切除与胰岛自体移植胰岛素依赖组在低血糖/高血糖相关住院就诊、目标范围内时间中位数(53.5%,IQR 36.5-68.5 vs 59.0%,IQR 43.3-67.5)及血糖变异系数(31.3%,IQR 28.3-35.0 vs 32.3%,IQR 28.7-35.5)相似。
- 14天CGM监测中,单纯全胰腺切除患者未观察到严重低血糖(<3.0 mmol/L)。
临床怎么用
- 全胰腺切除术后可借助现代胰岛素与CGM管理血糖,严重低血糖风险可能低于历史认知。
- 术前HbA1c较高的患者行单纯全胰腺切除需注意术后第一个月血糖控制。
- 该数据可辅助全胰腺切除与胰岛自体移植的手术决策及患者选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate risk of severe hypoglycemia after total pancreatectomy (TP). BACKGROUND: Historically, TP was feared due to loss of insulin and counter-regulatory hormones, as well as the risk of severe hypoglycemic events (SHE). While TP with islet auto-transplant (TPIAT) can preserve endocrine function, past studies reported 41% SHE incidence post-operatively. Advancements in insulin therapies and continuous glucose monitors (CGMs) have likely improved outcomes but are understudied in this population. METHODS: This single center study analyzed TP patients from 2009-2024. CGMs (Dexcom G7) were provided for the study if patients did not have one. Demographics, survival, emergency department visits, and glycemic control were assessed. RESULTS: Among 147 TP cases, 76 underwent TP alone and 71 TPIAT. In the TP-alone patients, two deaths (2/76; 2.63%) occurred due to hypoglycemia. Pre-operatively, TP-alone patients had higher HbA1c (7.1±2.2%) than TPIAT patients (5.9±1.3%; P<0.001). In the first month post-operatively, TP-alone patients had higher HbA1c than TPIAT-insulin dependent patients, but no difference over 10 years. Hypo/hyperglycemia-related hospital visits, median time in target range (TP: 53.5%, IQR: 36.5-68.5 vs. TPIAT insulin-dependent: 59.0%, IQR: 43.3-67.5), and glycemic variability (coefficient of variation; 31.3%, IQR 28.3-35.0 vs 32.3%, IQR 28.7-35.5) were similar between TP-alone and TPIAT-insulin dependent groups. In 14 days of CGM capture, no severe hypoglycemia was observed in TP-alone patients (<3.0 mmol/L). CONCLUSIONS: Advancements in insulins and CGMs provide acceptable outcomes after TP without supplemental islet transplantation, and lower risk of SHE than previously reported. This encouraging data may aid surgical decision-making and patient selection for surgery.
引用
- Czarnecka Z, Verhoeff K, Carr ALJ, et al. Risk of Recurrent Hypoglycemia and Long-term Survival after total Pancreatectomy: A Prospective Observational Study. Ann Surg. 2025. PMID: 40793922. doi:10.1097/SLA.0000000000006909
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。